10 Unstoppable Women in Healthcare & Pharma, 2025
ON THE COVER
Thermo Fisher Scientific
The healthcare and pharmaceutical industry is undergoing a profound transformation. With ground-breaking advancements in artificial intelligence, personalized medicine, and digital health, the development and delivery of treatments have evolved dramatically. Clinical trials have become more inclusive, ensuring equitable access to life-saving innovations. As the industry continues to push boundaries, visionary leaders driving progress stand at the forefront.
Embr Labs
Elizabeth Gazda is an accomplished leader in the healthcare and technology sectors. Her journey into the healthcare and pharmaceutical industry began after completing her third startup. She was introduced to Embr Labs and invited to join the team as CEO. The company’s mission and innovative product, the Embr Wave, immediately caught her attention.
Brand Medicine International
Julia Walsh’s journey in healthcare and pharma is marked by a passion for both the science and the art of the industry. With a background in biochemistry and pharmacology, she has always been fascinated by the science of life. However, it was the intersection of science and creativity that truly sparked her interest in the agency side of the industry. Her work has focused on creating innovative communication strategies that translate complex medical content into meaningful stories that connect patients with the treatments they need.
Propel Bio Partners
Dr. Leen Kawas is a distinguished leader in the biotechnology and pharmaceutical industry, currently serving as Managing General Partner at Propel Bio Partners, a venture capital firm based in Los Angeles. Her career has been marked by significant leadership roles, with extensive experience in drug development and strategic business growth. Before co-founding Propel Bio Partners, she was the CEO of a biotechnology company, where she successfully led multiple drug development cycles and guided the company through its initial public offering in September 2020.
Regis University
Dr. Leticia Shea’s journey into the healthcare and pharmaceutical industry began during her undergraduate studies when she discovered a deep passion for chemistry. This fascination gradually evolved into an interest in pharmacology, where she realized the profound impact that medications have on human health. Her scientific curiosity and desire to make a positive difference in people’s lives ultimately led her to pursue a career in pharmaceuticals.
RadNet
Dr. Suzie Bash is a distinguished Neuroradiologist with deep expertise in artificial intelligence (AI) applications in advanced neuroimaging which add patient-centric value and quality. Dr. Bash is a Medical Director and Neuroradiologist at RadNet. Prior to this she was on the faculty at UCLA as an Assistant Professor of Neuroradiology, after completing a 2-year Neuroradiology Fellowship and Residency also at UCLA.
Institute of Hope & Innovation
Hilda Agajanian
Hilda Agajanian, Chief Growth Officer at The Oncology Institute of Hope & Innovation, emerges as a pioneering figure in the healthcare sector, spearheading transformative changes in cancer care. With her unwavering dedication to optimizing patient satisfaction and outcomes, she stands as a beacon of innovation and compassion in the industry.
– A r t i c l e s –
